Recombinant Human Sp1 Protein，His & GST

Sp1, a transcription factor belonging to the specificity protein/Krüppel-like factor (Sp/KLF) family, plays a pivotal role in regulating gene expression across various biological processes, including cell growth, differentiation, and apoptosis. The study of Sp1 recombinant proteins has gained significant interest due to its involvement in numerous diseases, including cancer, where aberrant expression can lead to tumor progression and metastasis. Researchers have focused on engineering Sp1 recombinant proteins to understand its structural properties and functional mechanisms more comprehensively. This involves creating both full-length and truncated forms of Sp1 to determine critical domains responsible for DNA binding and transcriptional activation. Recent advances in recombinant DNA technology, such as CRISPR and advanced protein expression systems, have facilitated the production and purification of Sp1 proteins, allowing for detailed biochemical characterization and interaction studies. Furthermore, the use of Sp1 as a potential therapeutic target or biomarker is under investigation, particularly in the context of targeted cancer therapies. Understanding Sp1’s role through its recombinant forms could provide insights into novel therapeutic strategies, contributing to the development of drugs that can modulate its activity, thereby offering hope for improving treatment outcomes in various diseases. Overall, the exploration of Sp1 recombinant proteins not only enhances our fundamental understanding of gene regulation but also paves the way for innovative clinical applications.